NICE META Tool

Solution

If you are Medtech company who are either just starting your market access journey here in the UK or have been met with challenges in terms of adoption within NHS. Then a Medtech Early Technical Assessments (META) tool project could be the solution to better understand those challenges.

The process is a clearly defined one when completing META Tool, however with our team being the first to be trained by NICE and our experience of working with over 60 medical device companies in the last 5 years. We are therefore well placed to support medical device companies accelerate their access to the market. We have also supported over 15 National Institute for Health and Care Excellent (NICE) approvals which have enabled greater traction for those companies.

Benefits

Greater understanding of how the current body of evidence fits with the requirements of the NHS.

Look at the strength of cost and clinical effectiveness evidence.

Support a better understanding of how the technology will fit in the funding process within the NHS.

Help support and develop a value proposition in support of NHS Trusts, CCGs and NHS England adoption.

Ensure routes to market are understood and where to gather more evidence if required.

Stakeholders

Med-Tech
Venture Capitalists
Health Economists
Pharmaceuticals

We would welcome the opportunity to discuss the META Tool process with you and provide you with a free 30 minute consutation to understand your full requriements. Please feel free to reach out or read some of our blogs about the way we have supported other Medtech companies.